Posted by Michael Wonder on 02 Dec 2024
‘We dodged a bullet’: biotech and pharma react to selection of Marty Makary for FDA commissioner
23 November 2024 - Many appear cautiously optimistic about Trump’s intended pick.
STAT reporters reached out to key figures in biotech, pharma, and medical devices to find out what they think about President-elect Trump’s pick of Johns Hopkins pancreatic surgeon Martin “Marty” Makary as commissioner of the FDA. Makary, like Trump’s intended Health and Human Services selection, Robert F. Kennedy Jr., is part of the “Make America Healthy Again” movement, focused on addressing chronic disease. He was also a critic of some COVID-19 pandemic measure, including vaccine mandates.
